Clinical trial
Coherex WAVECREST I Left Atrial Appendage Occlusion Study
NCT02239887 is registered in ClinicalTrials.gov with Coherex Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Coherex WAVECREST I Left Atrial Appendage Occlusion Study
- Lead sponsor
- Coherex Medical
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- November 30, 2014
- Enrollment
- 155 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
anticoagulation indication for potential thrombus formation in the left atrium, laa anatomy amenable to treatment by percutaneous technique, non-valvular paroxysmal, persistent, or permanent atrial fibrillation